Cargando…

Vaso-nervorumitis: responsible for pain in Buerger’s disease?

Buerger’s disease (BD) is an episodic, inflammatory, and occlusive peripheral vascular disease with unknown etiology, which can lead to tissue or limb loss. BD patients usually present neurological symptoms from the early stages of the disease including numbness, cold sensation, and allodynia as the...

Descripción completa

Detalles Bibliográficos
Autores principales: Fazeli, Bahare, Farzadnia, Mahdi, Taheri, Hossein
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6503200/
https://www.ncbi.nlm.nih.gov/pubmed/31118831
http://dx.doi.org/10.2147/IMCRJ.S197862
_version_ 1783416375362977792
author Fazeli, Bahare
Farzadnia, Mahdi
Taheri, Hossein
author_facet Fazeli, Bahare
Farzadnia, Mahdi
Taheri, Hossein
author_sort Fazeli, Bahare
collection PubMed
description Buerger’s disease (BD) is an episodic, inflammatory, and occlusive peripheral vascular disease with unknown etiology, which can lead to tissue or limb loss. BD patients usually present neurological symptoms from the early stages of the disease including numbness, cold sensation, and allodynia as the disease progresses. Pain in the late stages of BD is very severe, almost resistant to opioid pain killers, and sometimes compels the patient to pursue major amputation. Therefore, pain management in BD patients is one of the most important and, at the same time, challenging issues since its main etiology is not well understood. Recently, a 39-year-old male smoker with a diagnosis of BD underwent a below-knee amputation in his left leg. Oddly, we found that the vasa-nervorum of the sural nerve had the pathological changes usually observed in BD, including inflammation and proliferation of endothelial cells. Notably, the inflammation was limited to the vasa-nervorum and did not extend to the nerve fascicles. Our findings could provide a clue to taking the approach of managing pain in BD as if it were vasculitis neuropathy; and the inflammation of the vasa-nervorum individually might be responsible for the pain characteristic of BD. In addition, our findings could indicate that BD is a systemic vasculitis of microcirculation and, hence, a different treatment approach for BD might be needed in addition to antithrombotic and vasodilator.
format Online
Article
Text
id pubmed-6503200
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Dove
record_format MEDLINE/PubMed
spelling pubmed-65032002019-05-22 Vaso-nervorumitis: responsible for pain in Buerger’s disease? Fazeli, Bahare Farzadnia, Mahdi Taheri, Hossein Int Med Case Rep J Case Report Buerger’s disease (BD) is an episodic, inflammatory, and occlusive peripheral vascular disease with unknown etiology, which can lead to tissue or limb loss. BD patients usually present neurological symptoms from the early stages of the disease including numbness, cold sensation, and allodynia as the disease progresses. Pain in the late stages of BD is very severe, almost resistant to opioid pain killers, and sometimes compels the patient to pursue major amputation. Therefore, pain management in BD patients is one of the most important and, at the same time, challenging issues since its main etiology is not well understood. Recently, a 39-year-old male smoker with a diagnosis of BD underwent a below-knee amputation in his left leg. Oddly, we found that the vasa-nervorum of the sural nerve had the pathological changes usually observed in BD, including inflammation and proliferation of endothelial cells. Notably, the inflammation was limited to the vasa-nervorum and did not extend to the nerve fascicles. Our findings could provide a clue to taking the approach of managing pain in BD as if it were vasculitis neuropathy; and the inflammation of the vasa-nervorum individually might be responsible for the pain characteristic of BD. In addition, our findings could indicate that BD is a systemic vasculitis of microcirculation and, hence, a different treatment approach for BD might be needed in addition to antithrombotic and vasodilator. Dove 2019-04-29 /pmc/articles/PMC6503200/ /pubmed/31118831 http://dx.doi.org/10.2147/IMCRJ.S197862 Text en © 2019 Fazeli et al. http://creativecommons.org/licenses/by-nc/3.0/ This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).
spellingShingle Case Report
Fazeli, Bahare
Farzadnia, Mahdi
Taheri, Hossein
Vaso-nervorumitis: responsible for pain in Buerger’s disease?
title Vaso-nervorumitis: responsible for pain in Buerger’s disease?
title_full Vaso-nervorumitis: responsible for pain in Buerger’s disease?
title_fullStr Vaso-nervorumitis: responsible for pain in Buerger’s disease?
title_full_unstemmed Vaso-nervorumitis: responsible for pain in Buerger’s disease?
title_short Vaso-nervorumitis: responsible for pain in Buerger’s disease?
title_sort vaso-nervorumitis: responsible for pain in buerger’s disease?
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6503200/
https://www.ncbi.nlm.nih.gov/pubmed/31118831
http://dx.doi.org/10.2147/IMCRJ.S197862
work_keys_str_mv AT fazelibahare vasonervorumitisresponsibleforpaininbuergersdisease
AT farzadniamahdi vasonervorumitisresponsibleforpaininbuergersdisease
AT taherihossein vasonervorumitisresponsibleforpaininbuergersdisease